Showing results (301-310 of 435) with videos related to

Sort By:
Pageof 44
Maturitas|June 1, 2025
Persistent gaps in menopause care: current recommendations of the POESIT groupCostantino Di Carlo, Angelo Cagnacci, Marco Gambacciani, et al.
Climacteric : the Journal of the International Menopause Society|August 7, 2025
Major adverse cardiovascular events risk in menopausal women treated with oral estradiol/micronized progesterone versus conjugated estrogens/medroxyprogesterone: a claims data analysis in the USAJohn C Stevenson, Rodney Baber, Risa Kagan, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|February 6, 2025
Signs and symptoms of vulvovaginal atrophy (VVA) in clinical practice - the possible involvement of thyroid autoimmunity in genitourinary syndrome of menopause (GSM)Laura Cucinella, Federica Barbagallo, Mariacristina Erroi, et al.
Maturitas|May 15, 2024
Effect of fezolinetant on sleep disturbance and impairment during treatment of vasomotor symptoms due to menopauseMarla Shapiro C M, Antonio Cano, Rossella E Nappi, et al.
Diabetes Care|January 31, 2006
Sexual function and endocrine profile in fertile women with type 1 diabetesAndrea Salonia, Roberto Lanzi, Marina Scavini, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|October 18, 2022
The views of women and pharmacists on the desirability of a progestogen-only pill over the counter. Results of a survey in Germany, Italy and SpainEmilio Arisi, Cosima Bauer, Manuela Farris, et al.
The Journal of Sexual Medicine|March 29, 2008
Menstrual cycle-related changes in circulating androgens in healthy women with self-reported normal sexual functionAndrea Salonia, Marina Pontillo, Rossella E Nappi, et al.
Journal of Pediatric and Adolescent Gynecology|November 17, 2023
Perimenstrual Asthma and Premenstrual Disorders in Adolescents with AsthmaValeria Calcaterra, Andrea Farolfi, Enza D'Auria, et al.
BMJ (Clinical Research Ed.)|November 18, 2024
Efficacy and safety of fezolinetant for moderate-severe vasomotor symptoms associated with menopause in individuals unsuitable for hormone therapy: phase 3b randomised controlled trialKatrin Schaudig, Xuegong Wang, Céline Bouchard, et al.
The Journal of Sexual Medicine|April 26, 2021
The Gynogram: A Multicentric Validation of a New Psychometric Tool to Assess Coital Pain Associated With VVA and Its Impact on Sexual Quality of Life in Menopausal WomenRossella E Nappi, Alessandra Graziottin, Daniele Mollaioli, et al.
Pageof 44